Jen Seda, MD excels in developing business-aligned medical strategies and translating these into proven tactical execution via strategic R&D, payer evidence generation, KOL relationships, influential publications, behavior changing education and medical messaging, with budgets ranging from less than $50k to over $20 million. She brings this expertise to SSI strategy, building custom medical landscape-based solutions with clients of all sizes and stages of development.
Dr. Jen Seda most recently served as Vice President of Market Access, Government and Medical Affairs at TerumoBCT, a global device company with products in hematology, neurology, critical care, orthopedics and stem cell technologies. Previously, she led the Global Medical Affairs team at Baxter Healthcare, Biologics division through launches in rare disease in pulmonology and neurology. She has helped build strong and effective medical affairs and medical information teams from scratch at Coviden, Respiratory and Monitoring division and has led both medical affairs and marketing teams at Talecris Biotherapeutics to market leadership in orphan disease.
Dr. Seda received her medical degree and training in neuroimmunology at the Mayo Clinic and undergraduate from U.C. Irvine, with additional experience running bench science and basic research experience at the clinic and at Amgen, allowing her insight to strategic and practical planning from bench to bedside in pharma, device and wellness.